Ipamorelin + CJC-1295 (No DAC)
Größe pro Vial: 5 mg + 5 mg
€74.90
Two-component blend: Ipamorelin and CJC-1295 (No DAC), 5 mg each per vial – for receptor-based binding research.
In stock
IC-023503
July 2026
PDF ↓Scientific data sheet
- CAS number
- 170851-70-4 (Ipamorelin) · 863288-34-0 (CJC-1295 No DAC)
- Molecular formula
- C₃₈H₄₉N₉O₅ (Ipamorelin) · C₁₅₂H₂₅₂N₄₄O₄₂ (CJC-1295 No DAC)
- Purity
- ≥99% (HPLC-verified)
- Sequence
- 5 amino acid + 29 amino acid peptide (blend)
- Class
- Blend: GHS-R1a agonist + GHRH analogueueueueueue
- Appearance
- White lyophilised cake
→ Vollständiges Wirkstoff-Datenblatt
A blend of Ipamorelin (5 mg) and CJC-1295 without DAC / Mod GRF 1-29 (5 mg) in one vial. Supplied as a lyophilised powder. External HPLC/LC-MS testing per batch, including Certificate of Analysis. For research purposes only.
- Form
- Lyophilised powder
- Container
- Glass vial, sealed
- Solvent
- Not included
- Testing
- HPLC, LC-MS, identity testing
- Origin
- Synthetic
- Purity
- ≥99% (HPLC-verified)
- Amount
- 5 mg + 5 mg
Every batch is tested by HPLC and LC-MS at an independent third-party laboratory and shipped with a certificate of analysis.
- 5/5 mg · IC-023503 COA (PDF)
Store cool, dry and protected from light. Lyophilised powder recommended at 2–8 °C; −20 °C for longer storage.
For research use only (RUO). This product is intended exclusively for scientific laboratory research. Not for human consumption, not for therapeutic use and not for veterinary purposes. No dosage recommendations, no health claims.
